Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Genzyme, Arecor Enter Protein Pact | Contract Pharma

What are you searching for?

Sign in
Breaking News, Collaborations & Alliances

Genzyme, Arecor Enter Protein Pact

Genzyme Corp. and Arecor Ltd. have entered an extensive collaboration agreement to develop advanced formulations for protein therapeutics.

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Genzyme Corp. and Arecor Ltd. have entered an extensive collaboration agreement to develop advanced formulations for protein therapeutics. The two companies will work together to develop stable, high strength formulations of labile biomolecules.

Dr. Robert Mattaliano, group vice president of Therapeutic Protein R&D commented, “The Arecor technology has a demonstrated potential to significantly improve the stability of complex biologicals by using novel formulation design principles. Genzyme is pleased to establish this strategic partnership in support of our goal to provide stable and convenient dosage forms to patients and their caregivers.”

Tom Saylor, chief executive officer of Arecor said, “Formulation of the next generation of biologics represents unique challenges to developers. Arecor has developed a strong partnership with Genzyme and is privileged to work closely with one of the world leaders in biotechnology to help enable new protein-based therapeutics.”

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters